Retinal toxicity of cyclosporine intravitreally delivered by a biodegradable implant in rabbits (2010)
- Authors:
- USP affiliated authors: JORGE, RODRIGO - FMRP ; MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP
- Unidade: FMRP
- Subjects: DOENÇAS RETINIANAS; ELETRORRETINOGRAFIA; FÁRMACOS (EFEITOS)
- Language: Inglês
- Imprenta:
- Publisher place: Fort Lauderdale
- Date published: 2010
- Source:
- Título do periódico: Abstracts
- Conference titles: Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
-
ABNT
ALMEIDA, F. P. et al. Retinal toxicity of cyclosporine intravitreally delivered by a biodegradable implant in rabbits. 2010, Anais.. Fort Lauderdale: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 20 maio 2024. -
APA
Almeida, F. P., Ribeiro, J. A. S., Siqueira, R. C., Silva-Cunha, A., Saliba, J. B., Jorge, R., & Messias, A. M. V. (2010). Retinal toxicity of cyclosporine intravitreally delivered by a biodegradable implant in rabbits. In Abstracts. Fort Lauderdale: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Almeida FP, Ribeiro JAS, Siqueira RC, Silva-Cunha A, Saliba JB, Jorge R, Messias AMV. Retinal toxicity of cyclosporine intravitreally delivered by a biodegradable implant in rabbits. Abstracts. 2010 ;[citado 2024 maio 20 ] -
Vancouver
Almeida FP, Ribeiro JAS, Siqueira RC, Silva-Cunha A, Saliba JB, Jorge R, Messias AMV. Retinal toxicity of cyclosporine intravitreally delivered by a biodegradable implant in rabbits. Abstracts. 2010 ;[citado 2024 maio 20 ] - Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema
- Intravitreal autologous bone marrow derived stem cells in ischemic macular edema: results after 6 months follow-up
- Dark-adapted b-wave luminance function: comparison of two mathematical models in normal subjects and in patients with retinal dystrophy
- Macular laser photocoagulation combined with intravitreal bevacizumab or triamcinolone for diabetic macular edema
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas